BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 16075755)

  • 1. Influence of hepatitis B and hepatitis C virus infection on the outcome of kidney transplantation.
    Yuan CH; Liu YF; Li GC
    Chin Med Sci J; 2005 Jun; 20(2):129-32. PubMed ID: 16075755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of hepatitis B and C virus infection on the outcome of kidney transplantation in Chinese patients.
    Huo TI; Yang WC; Wu JC; King KL; Loong CC; Lin CY; Lui WY; Chang FY; Lee SD
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):93-100. PubMed ID: 10677918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of hepatitis B and C virus infection on graft function after renal transplantation.
    Behzad-Behbahani A; Mojiri A; Tabei SZ; Farhadi-Andarabi A; Pouransari R; Yaghobi R; Rahsaz M; Banihashemi M; Malek-Hosseini SA; Javid A; Bahador A; Reisjalali A; Behzadi S; Salehipour M; Salahl A; Davari R; Janghorban P; Torb A; Salah AR
    Transplant Proc; 2005 Sep; 37(7):3045-7. PubMed ID: 16213299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.
    Fattovich G; Pantalena M; Zagni I; Realdi G; Schalm SW; Christensen E;
    Am J Gastroenterol; 2002 Nov; 97(11):2886-95. PubMed ID: 12425564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of hepatitis B and C virus on kidney transplantation outcome.
    Mathurin P; Mouquet C; Poynard T; Sylla C; Benalia H; Fretz C; Thibault V; Cadranel JF; Bernard B; Opolon P; Coriat P; Bitker MO
    Hepatology; 1999 Jan; 29(1):257-63. PubMed ID: 9862875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term impact of hepatitis B, C virus infection on renal transplantation.
    Lee WC; Shu KH; Cheng CH; Wu MJ; Chen CH; Lian JC
    Am J Nephrol; 2001; 21(4):300-6. PubMed ID: 11509802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of kidney transplantation in HBsAG and anti-HCV seropositive renal allograft recipients.
    Durlik M; Gaciong Z; Soluch L; Rowińska D; Kozłowska-Boszko B; Rowiński W; Szmidt J; Lao M
    Transplant Proc; 1996 Dec; 28(6):3459-60. PubMed ID: 8962347
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of hepatitis B and C virus infections on kidney transplantation: a single center experience.
    Santos L; Alves R; Macario F; Parada B; Campos M; Mota A
    Transplant Proc; 2009 Apr; 41(3):880-2. PubMed ID: 19376378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ten-year follow-up of kidney transplantation from hepatitis B surface antigen-positive donors.
    Sumethkul V; Ingsathit A; Jirasiritham S
    Transplant Proc; 2009; 41(1):213-5. PubMed ID: 19249516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of hepatitis B and hepatitis C virus infections on patients and allograft outcomes in renal transplant recipients: a single center study.
    Ghafari A; Sanadgol H
    Transplant Proc; 2008; 40(1):196-8. PubMed ID: 18261585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occult hepatitis B in renal transplant patients.
    Peres AA; Dias EA; Chesky M; Alvares-da-Silva MR; Jobim LF; Gonçalves LF; Manfro RC
    Transpl Infect Dis; 2005 Jun; 7(2):51-6. PubMed ID: 16150090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational use of polymerase chain reaction--based detection of viral genomes in patients with serologic markers of hepatitis B or C virus infection.
    Pfeffel F; Oesterreicher C; Penner E; Ferenci P; Sillaber C; Fiedler R; Müller C
    Wien Klin Wochenschr; 1997 Jan; 109(1):20-4. PubMed ID: 9037744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long term effect of hepatitis B and C virus infection on the survival of kidney transplant patients].
    Corrêa JR; Rocha FD; Peres AA; Gonçalves LF; Manfro RC
    Rev Assoc Med Bras (1992); 2003; 49(4):389-94. PubMed ID: 14963590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of hepatitis B virus and hepatitis C virus in patients with human immunodeficiency virus infection in Central China.
    Chen X; He JM; Ding LS; Zhang GQ; Zou XB; Zheng J
    Arch Virol; 2013 Sep; 158(9):1889-94. PubMed ID: 23553454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and clinical course of hepatitis B and hepatitis C liver disease in ciclosporin-treated renal allograft recipients.
    Bang BK; Yang CW; Yoon SA; Kim YS; Chang YS; Yoon YS; Koh YB
    Nephron; 1995; 70(4):397-401. PubMed ID: 7477642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The long-term course of chronic hepatitis B.
    Di Marco V; Lo Iacono O; Cammà C; Vaccaro A; Giunta M; Martorana G; Fuschi P; Almasio PL; Craxì A
    Hepatology; 1999 Jul; 30(1):257-64. PubMed ID: 10385664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence of hepatitis B and C viral markers in patients with primary hepatocellular carcinoma in Singapore.
    Khin LW; Teo CJ; Guan R
    Singapore Med J; 1996 Oct; 37(5):492-6. PubMed ID: 9046201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
    Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
    J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Investigation of hemodialysis patients in terms of the presence of occult hepatitis B].
    Altindiş M; Uslan I; Cetinkaya Z; Yüksel S; Ciftçi IH; Demirtürk N; Ozdemir M; Arslan F; Aktepe OC
    Mikrobiyol Bul; 2007 Apr; 41(2):227-33. PubMed ID: 17682709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different impacts of hepatitis B virus and hepatitis C virus on the outcome of kidney transplantation.
    Ingsathit A; Thakkinstian A; Kantachuvesiri S; Sumethkul V
    Transplant Proc; 2007 Jun; 39(5):1424-8. PubMed ID: 17580153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.